×
Entrez Id:
5889
Gene Symbol:
RAD51C
RAD51C
0.700
Biomarker
disease
GENOMICS_ENGLAND
×
Entrez Id:
999
Gene Symbol:
CDH1
CDH1
0.690
Biomarker
disease
GENOMICS_ENGLAND
×
Entrez Id:
5395
Gene Symbol:
PMS2
PMS2
0.630
Biomarker
disease
GENOMICS_ENGLAND
×
Entrez Id:
22800
Gene Symbol:
RRAS2
RRAS2
0.600
Biomarker
disease
GENOMICS_ENGLAND
×
Entrez Id:
5892
Gene Symbol:
RAD51D
RAD51D
0.600
Biomarker
disease
GENOMICS_ENGLAND
×
Entrez Id:
2956
Gene Symbol:
MSH6
MSH6
0.570
Biomarker
disease
GENOMICS_ENGLAND
×
Entrez Id:
5071
Gene Symbol:
PRKN
PRKN
0.550
Biomarker
disease
GENOMICS_ENGLAND
×
Entrez Id:
1499
Gene Symbol:
CTNNB1
CTNNB1
0.900
GeneticVariation
disease
UNIPROT
Both nuclear and cytoplasmic beta-catenin expressions were demonstrated in 4 of the 27 ovarian carcinomas for which tissue samples were available for examination.
10391090
1999
×
Entrez Id:
672
Gene Symbol:
BRCA1
BRCA1
0.800
GeneticVariation
disease
UNIPROT
We identified the BRCA1 /2 genetic mutation test results of 1223 breast cancer patients and 174 patients with ovarian cancer .
28364669
2017
×
Entrez Id:
672
Gene Symbol:
BRCA1
BRCA1
0.800
GeneticVariation
disease
UNIPROT
One hundred and seven ovarian cancer cases were analyzed for BRCA1 alterations using the RNase mismatch cleavage assay followed by direct sequencing.
10196379
1999
×
Entrez Id:
672
Gene Symbol:
BRCA1
BRCA1
0.800
GeneticVariation
disease
UNIPROT
The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer : no evidence for other ovarian cancer -susceptibility genes.
10486320
1999
×
Entrez Id:
672
Gene Symbol:
BRCA1
BRCA1
0.800
GeneticVariation
disease
UNIPROT
Four additional missense variants (one in BRCA1 and three in BRCA2) with a possible association with an increased risk ovarian cancer were revealed, resulting in a total frequency of BRCA gene alterations of 17/161 (11%).
14746861
2004
×
Entrez Id:
675
Gene Symbol:
BRCA2
BRCA2
0.800
GeneticVariation
disease
UNIPROT
×
Entrez Id:
83990
Gene Symbol:
BRIP1
BRIP1
0.700
GeneticVariation
disease
UNIPROT
×
Entrez Id:
5290
Gene Symbol:
PIK3CA
PIK3CA
0.700
GeneticVariation
disease
UNIPROT
Our study is the first direct evidence that PIK3CA is an oncogene in ovarian cancer and greatly extends recent findings in breast cancer.
15520168
2004
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
0.700
GeneticVariation
disease
UNIPROT
Lung cancer: intragenic ERBB2 kinase mutations in tumours.
15457249
2004
×
Entrez Id:
2064
Gene Symbol:
ERBB2
ERBB2
0.700
GeneticVariation
disease
UNIPROT
Patterns of somatic mutation in human cancer genomes.
17344846
2007
×
Entrez Id:
999
Gene Symbol:
CDH1
CDH1
0.690
GeneticVariation
disease
UNIPROT
×
Entrez Id:
4978
Gene Symbol:
OPCML
OPCML
0.610
GeneticVariation
disease
UNIPROT
These findings suggest that OPCML is an excellent candidate for the 11q25 ovarian cancer TSG.
12819783
2003
×
Entrez Id:
673
Gene Symbol:
BRAF
BRAF
0.600
GeneticVariation
disease
UNIPROT
×
Entrez Id:
22800
Gene Symbol:
RRAS2
RRAS2
0.600
GeneticVariation
disease
UNIPROT
×
Entrez Id:
6794
Gene Symbol:
STK11
STK11
0.550
GeneticVariation
disease
UNIPROT
×
Entrez Id:
8626
Gene Symbol:
TP63
TP63
0.530
GeneticVariation
disease
UNIPROT
×
Entrez Id:
1801
Gene Symbol:
DPH1
DPH1
0.340
GeneticVariation
disease
UNIPROT
×
Entrez Id:
4361
Gene Symbol:
MRE11
MRE11
0.320
GeneticVariation
disease
UNIPROT